CSI Market
Sign In | Register

Cellebrite Di Ltd (CLBT) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CLBT Annual Cash Flow →
Cash flow data covering Cellebrite Di Ltd–Dec 31 2024 offers a view into how Dec 31 2025's cash position has developed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		0 0 0 (Dec 31 2024)
Operating Activities
Income78.33
Depreciation & amortization6.97
Amortization of Other Assets4.90
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-1.63
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation44.89
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants0.00
Adjustments For Fair Value Adjustments Of Restricted Sponsor Shares And Price Adjustment Share Liabilities-
Investment Income Net Amortization Of Discount And Premium-
Interest Income Deposits With Financial Institutions-
Adjustments For Fair Value Adjustments Of Restricted Sponsor Shares-
Adjustments For Fair Value Adjustments Of Price Adjustment Share Liabilities-
Increase Decrease In Operating Lease Right Of Use Assets-
Increase Decrease In Contract With Customer Liability-
Income taxes0.08
Losses/ -gains on Investments net0.00
Accounts Receivable15.78
Increase (Decrease) in Accounts Payable, Trade4.94
Increase (Decrease) in Pension and Postretirement Obligations0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-5.61
Other Working Capital6.94
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities2.31
Discontinued operations0.00
Net Cash flow from Operating Activities173.54
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds187.00
Payments to Acquire Marketable Securities321.23
Real Estate Investments0.00
Proceeds From Sales Of Marketable Securities-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired147.46
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-268.25
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock4.96
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-191.66
Proceeds From Recapitalization Transaction Net-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Redemption Of Public Warrants-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities25.05
Effect of exchange rate on cash flow2.45
Discontinued operations0.00
Free Cash Flow173.54
Total Cash Flow-69.65
4 historic quarters locked

Sign in to unlock the full Cellebrite Di Ltd cash flow history.

Sign In Create Free Account

About Cellebrite Di Ltd Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 20-F filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-26-013790

Figures are derived from filed reports and may be restated. Historical data is subject to revision.